Interaction	interaction	O	O	O	O
between	between	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
levofloxacin	levofloxacin	CHEMICALS	O	OTHERS	I
:	:	O	O	O	O
case	case	O	O	O	O
series	series	O	O	O	O
.	.	O	O	O	O

Warfarin	warfarin	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
widely	widely	O	O	O	O
used	used	O	O	O	O
oral	oral	O	O	O	O
anticoagulant	anticoagulant	O	O	O	O
and	and	O	O	O	O
is	is	O	O	O	O
indicated	indicated	O	O	O	O
for	for	O	O	O	O
many	many	O	O	O	O
clinical	clinical	O	O	O	O
conditions	conditions	O	O	O	O
.	.	O	O	O	O

Levofloxacin	levofloxacin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
fluoroquinolone	fluoroquinolone	O	O	OTHERS	I
,	,	O	O	O	O
is	is	O	O	O	O
one	one	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
commonly	commonly	O	O	O	O
prescribed	prescribed	O	O	O	O
antibiotics	antibiotics	O	O	O	O
in	in	O	O	O	O
clinical	clinical	O	O	O	O
practice	practice	O	O	O	O
and	and	O	O	O	O
is	is	O	O	O	O
effective	effective	O	O	O	O
against	against	O	O	O	O
Gram-positive	gram-positive	O	O	O	O
,	,	O	O	O	O
Gram-negative	gram-negative	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
atypical	atypical	O	O	O	O
bacteria	bacteria	O	O	O	O
.	.	O	O	O	O

While	while	O	O	O	O
small	small	O	O	O	O
prospective	prospective	O	O	O	O
studies	studies	O	O	O	O
have	have	O	O	O	O
not	not	O	O	O	O
revealed	revealed	O	O	O	O
any	any	O	O	O	O
significant	significant	O	O	O	O
drug-drug	drug-drug	O	O	O	O
interaction	interaction	O	O	O	O
between	between	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
levofloxacin	levofloxacin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
several	several	O	O	O	O
case	case	O	O	O	O
reports	reports	O	O	O	O
have	have	O	O	O	O
indicated	indicated	O	O	O	O
that	that	O	O	O	O
levofloxacin	levofloxacin	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
significantly	significantly	O	O	O	O
potentiate	potentiate	O	O	O	O
the	the	O	O	O	O
anticoagulation	anticoagulation	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
3	3	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
serious	serious	O	O	O	O
bleeding	bleeding	O	DISEASE	OTHERS	I
complications	complications	O	O	O	O
that	that	O	O	O	O
appear	appear	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
the	the	O	O	O	O
result	result	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
interaction	interaction	O	O	O	O
between	between	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
levofloxacin	levofloxacin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Physicians	physicians	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
potential	potential	O	O	O	O
interaction	interaction	O	O	O	O
and	and	O	O	O	O
use	use	O	O	O	O
caution	caution	O	O	O	O
when	when	O	O	O	O
prescribing	prescribing	O	O	O	O
levofloxacin	levofloxacin	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
patients	patients	O	O	O	O
taking	taking	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

